The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

regenesance.com

Stage

Seed | Alive

About Regenesance

Regenesance is a specialty pharmaceutical company developing drugs to treat acute and chronic nerve disorders.

Regenesance Headquarter Location

Meibergdreef 45 R-Noord 01-152

1105 BA,

Netherlands

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Regenesance Patents

Regenesance has filed 7 patents.

The 3 most popular patent topics include:

  • Complement system
  • Clusters of differentiation
  • Immune system
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/16/2017

6/9/2020

Complement system, Clusters of differentiation, Immune system, Immunology, Monoclonal antibodies

Grant

Application Date

6/16/2017

Grant Date

6/9/2020

Title

Related Topics

Complement system, Clusters of differentiation, Immune system, Immunology, Monoclonal antibodies

Status

Grant

  • What is Regenesance's latest funding round?

    Regenesance's latest funding round is Seed.

  • Who are the investors of Regenesance?

    Investors of Regenesance include Life Sciences Fund Amsterdam.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.